Table 1.
Demographic information and antibiotic resistance rates
| Group | Total, n (%) | Antibiotic-Resistance Phenotypes, n (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Amoxicillin-R/mono-R | Metronidazole-R/mono-R | Clarithromycin-R/mono-R | Levofloxacin-R/mono-R | Metronidazole-clarithromycin dual-R | Metronidazole-levofloxacin dual-R | Clarithromycin-levofloxacin dual-R | MDR | Susceptible to four antibiotics | ||
| Gender | ||||||||||
| Male | 61 (54.5) | 0 (0)/0 (0) | 40 (65.6)/23 (37.7) | 8 (13.1)/3 (4.9) | 19 (31.1)/4 (6.6) | 2 (3.3) | 12 (19.7) | 0 (0) | 3 (4.9) | 14 (23.0) |
| Female | 51 (45.5) | 0 (0)/0 (0) | 33 (64.7)/15 (29.4) | 10 (19.6)/0 (0) | 20 (39.2)/1 (2.0) | 2 (3.9) | 11 (21.6) | 3 (5.9) | 5 (9.8) | 14 (23.0) |
| Age | ||||||||||
| 19–29 | 8 (7.1) | 0 (0)/0 (0) | 5 (62.5)/2 (25.0) | 2 (25.0)/1 (12.5) | 3 (37.5)/0 (0) | 0 (0) | 2 (25.0) | 0 (0) | 1 (12.5) | 2 (25.0) |
| 30–39 | 18 (16.1) | 0 (0)/0 (0) | 8 (44.4)/7 (38.9) | 3 (16.7)/2 (11.1) | 3 (16.7)/3 (16.7) | 1 (5.6) | 0 (0) | 0 (0) | 0 (0) | 5 (27.8) |
| 40–49 | 17 (15.2) | 0 (0)/0 (0) | 12 (70.6)/6 (35.3) | 4 (23.5)/0 (0) | 6 (35.3)/0 (0) | 1 (5.9) | 3 (17.6) | 1 (5.9) | 2 (11.8) | 4 (23.5) |
| 50–59 | 29 (25.9) | 0 (0)/0 (0) | 20 (69.0)/10 (34.5) | 4 (13.8)/0 (0) | 9 (31.0)/0 (0) | 2 (6.9) | 7 (24.1) | 1 (3.4) | 1 (3.4) | 8 (27.6) |
| 60–69 | 27 (24.1) | 0 (0)/0 (0) | 20 (74.1)/11 (40.7) | 2 (7.41)/0 (0) | 11 (40.7)/1 (3.7) | 0 (0) | 8 (29.6) | 1 (3.7) | 1 (3.7) | 5 (18.5) |
| 70–79 | 13 (11.6) | 0 (0)/0 (0) | 6 (46.2)/2 (15.4) | 2 (15.4)/0 (0) | 6 (46.2)/1 (7.7) | 0 (0) | 2 (15.4) | 0 (0) | 2 (15.4) | 4 (30.8) |
| 80 < | 2 (1.8) | 0 (0)/0 (0) | 2 (100)/0(0) | 1 (50)/0(0) | 1 (50)/0(0) | 0 (0) | 1 (50) | 0 (0) | 1 (50) | 0 (0) |
| Gastroscopy diagnosis | ||||||||||
| Chronic superficial gastritis | 19 (17.0) | 0 (0)/0 (0) | 8(42.1)/5(26.3) | 2(10.5)/1(5.3) | 5(26.3)/2(10.5) | 0(0) | 2(10.5) | 0(0) | 1(5.3) | 8(42.1) |
| Chronic atrophic gastritis | 66 (58.9) | 0 (0)/0 (0) | 46(69.7)/20(30.3) | 13(19.7)/0(0) | 29(43.9)/3(4.5) | 3(4.5) | 16(24.2) | 3(4.5) | 7(10.6) | 14(21.2) |
| Gastric/Duodenal ulcer | 26 (23.2) | 0 (0)/0 (0) | 18(69.2)/12(46.2) | 3(11.5)/2(7.7) | 5(19.2)/0(0) | 1(3.8) | 5(19.2) | 0 (0) | 0 (0) | 6(23.1) |
| Gastric cancer | 1 (0.9) | 0 (0)/0 (0) | 1(100)/1(100) | 0 (0)/0 (0) | 0 (0)/0 (0) | 0 (0)/0 (0) | 0 (0)/0 (0) | 0 (0)/0 (0) | 0 (0)/0 (0) | 0 (0)/0 (0) |
| Total | 112 | 0 (0)/0 (0) | 73 (65.2)/38 (33.9) | 18 (16.1)/3 (2.7) | 39 (34.8)/5 (4.5) | 4 (3.6) | 23 (20.5) | 3 (2.7) | 8 (7.1) | 28 (25.0) |